Home Science Pharmacokinetic and Bioavailability Evaluation of Cardiotrition® Booster

Pharmacokinetic and Bioavailability Evaluation of Cardiotrition® Booster

Cardiotrition® Booster is an advanced mitochondrial bioenergetic formulation combining liposomal Coenzyme Q10, liposomal R-alpha lipoic acid, and enhanced acetyl-L-carnitine, designed to overcome the limited oral bioavailability of conventional formulations.

A randomized, double-blind crossover study in 20 healthy volunteers demonstrated significantly improved bioavailability of all three ingredients compared with conventional formulations. Liposomal CoQ10 achieved a 2.56-fold increase in systemic exposure, while liposomal R-ALA showed a 2.71-fold increase. Enhanced acetyl-L-carnitine demonstrated a 1.42-fold increase. All formulations were well tolerated, with no serious adverse events reported.

These findings highlight the effectiveness of advanced delivery technologies in enhancing the absorption and systemic availability of key mitochondrial nutrients. Cardiotrition® Booster therefore offers a promising approach to supporting mitochondrial energy production and cardiac bioenergetics through improved nutrient delivery.

Related Products

YOUR CART
Free shipping on orders over three items

Your cart is empty